ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0513

Impact of Pregnancy on Sacroiliac Imaging in Women with Axial Spondyloarthritis: Results of the Analysis of the DESIR Cohort

Elodie Portier1, Maxime Dougados2, Adeline Ruyssen-Witrand3 and Anna Molto4, 1Hôpital Cochin, Paris, France, 2Rheumatology Department, Cochin Hospital; INSERM (U1153): Clinical Epidemiology and Biostatistics, University of Paris, Paris, France, 3Toulouse University Hospital, Toulouse, France, 4HOPITAL COCHIN AP-HP, Service de Rhumatologie, Paris, France

Meeting: ACR Convergence 2023

Keywords: Epidemiology, Imaging, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0510–0542) Spondyloarthritis Including Psoriatic Arthritis – Treatment: AxSpA Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Axial spondyloarthritis (axSpA) is typically characterized by imaging (radiographs or MRI) abnormalities of the sacroiliac joints (SIJ). Also, inflammatory lesions of the SIJ have been observed in healthy women post-partum. However, the impact of pregnancy on imaging abnormalities in women with axSpA is unknown.

The objective of this study was to evaluate impact of pregnancy on SIJ imaging in patients with early axSpA.

Methods: Women with axSpA from the French prospective cohort DESIR were included, with a follow-up of 5 years. Description of demographic and disease criteria, and SIJ imaging abnormalities at baseline was performed in all women, then according to antecedent of pregnancy. Secondly, changes on imaging over time were analyzed in the 38 women who were nulligravidae at baseline and became pregnant during follow up, using paired-test and then mixed models.

Results: 381 patients were included in the analysis. At baseline, women nulligravidae (142, 37%) were younger and had higher education level than other women with axSpA. Presence of sacroiliitis on MRI and X-ray were more frequent in women nulligravidae (16.9% vs 9.9%, p = 0.046 and 33.8% vs 19.4%, p = 0.0016, respectively) (table 1).

When focusing on incident pregnancies, these patients had more sacroiliitis on X-ray and MRI at baseline than patients nulligravidae at the end of follow-up and patients with past pregnancy, but had lower BASFI and ASDAS-CRP. Only left SIJ was statistically different after delivery, with mean scores of 0.67 and 0.95 before and after delivery (table 2). No impact of pregnancy on continuous imaging score was found with the different mixed models.

Conclusion: Pregnancy does not seem to aggravate imaging of axSpA women when comparing imaging according to the antecedent of pregnancy. Following axSpA patients who had first pregnancy showed mild increase of left sacroiliitis score on X-ray after delivery, but not enough to be considered as “worsening”.

Supporting image 1

Table 1: Imaging characteristics of women with axSpA according to antecedent of pregnancy at baseline, and statistical analysis with Student test or Chi-square (for continuous and binary variables, respectively).

Supporting image 2

Table 2: Imaging characteristics in women with axSpA who had first pregnancy during follow up, with description before/after delivery and paired-test with Mc Nemar of Student test (for binary and continuous variables, respectively).


Disclosures: E. Portier: None; M. Dougados: AbbVie, 2, 5, Bristol Myers Squibb, 2, 5, Eli Lilly, 2, 5, MSD, 2, 5, Novartis, 2, 5, Pfizer Inc, 2, 5, Roche, 2, 5, UCB, 2, 5; A. Ruyssen-Witrand: None; A. Molto: None.

To cite this abstract in AMA style:

Portier E, Dougados M, Ruyssen-Witrand A, Molto A. Impact of Pregnancy on Sacroiliac Imaging in Women with Axial Spondyloarthritis: Results of the Analysis of the DESIR Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/impact-of-pregnancy-on-sacroiliac-imaging-in-women-with-axial-spondyloarthritis-results-of-the-analysis-of-the-desir-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-pregnancy-on-sacroiliac-imaging-in-women-with-axial-spondyloarthritis-results-of-the-analysis-of-the-desir-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology